Showing results (131-140 of 242) with videos related to
Sort By:
Pageof 25
Cancer|July 26, 2017
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation ConsortiumRathi N Pillai, Madhusmita Behera, Lynne D Berry, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2012
Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapySamir E Witta, Robert M Jotte, Katrik Konduri, et al.Seminars in Oncology|March 15, 2002
Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancerPaul A Bunn, Daniel C Chan, Keith Earle, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
EGFR and HER2 genomic gain in recurrent non-small cell lung cancer after surgery: impact on outcome to treatment with gefitinib and association with EGFR and KRAS mutations in a Japanese cohortMarileila Varella-Garcia, Tetsuya Mitsudomi, Yashushi Yatabe, et al.Lung Cancer (Amsterdam, Netherlands)|February 22, 2023
CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung CancerJacob Langston, Tejas Patil, D Ross Camidge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase II study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancerChristian Monnerat, Thierry Le Chevalier, Karen Kelly, et al.Cancer Letters|October 29, 2010
ZEB1-responsive genes in non-small cell lung cancerRobert M Gemmill, Joëlle Roche, Vincent A Potiron, et al.Cancer Prevention Research (Philadelphia, Pa.)|July 17, 2019
A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former SmokersRobert L Keith, Patrick J Blatchford, Daniel T Merrick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2006
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancerNasser Hanna, Paul A Bunn, Corey Langer, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non-Small Cell Lung Cancer and Rate of Central Nervous System Progression on CrizotinibTejas Patil, Derek E Smith, Paul A Bunn, et al.Pageof 25